Short answer
JOINT Corp (JYNT) filed its Q1 2026 10-Q quarterly report on May 8, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $15M (up 13.3% year over year) with net income of $1M.
Q1 2026 key financials · XBRL
- Revenue
- $15M
- +13.3% YoY
- Net income
- $1M
- +62.1% YoY
- Operating margin
- 5.9%
- EPS (diluted)
- $0.09
- +80.0% YoY
Source: XBRL data from the JOINT Corp (JYNT) Q1 2026 10-Q on SEC EDGAR. USD.
JOINT Corp Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $14.8M, up 13.3% YoY from $13.1M, driven by advertising fund revenue up 58.1%
- Operating margin 5.9% vs (5.2)% YoY, with operating income $0.9M versus loss of $0.7M
- Franchise Operations strongest revenue line: advertising fund revenue $3.6M, up 58.1%; royalty fees weakest, down 0.5% to $8.0M
- Cash $20.7M; operating cash use $1.5M versus $3.7M YoY; $1.1M stock repurchases
- Outlook: volatile 2026 macro environment, labor shortages, wage inflation, elevated interest rates and weaker clinic sales headwinds
Risk Factors
- No risk-factors section provided; supplied text covers repurchases, exhibits, and signatures
- Share-repurchase authorization increased by $12.0 million, creating market-timing and liquidity exposure
- Repurchases totaled 137,088 shares at $8.35 average through March 31, 2026
- Credit-agreement waiver and fourth amendment dated May 1, 2026, indicating potential covenant or financing pressure
- Elite Chiro Group asset purchase agreement and amendment dated April 20 and April 27, 2026, creating transaction-execution risk
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other JOINT Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.